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ScienceDirectThe mammalian cell lines HEK293 and CHO have become
important expression hosts in structural biology. Generating
stable mammalian cell lines remains essential for studying the
function and structure of recombinant proteins, despite the
emergence of highly efficient transient transfection protocols.
Production with stable cell lines can be scaled up easily and high
volumetric product yield can be achieved. Protein structure
reports of the past two years that used stable cell lines were
surveyed for this review. Well-established techniques and novel
approaches for generating stable cell lines and stable cell pools
are presented, including cell sorting, site-specific recombination,
transposons, the Lentivirus system and phage integrases. Host
cell line optimization by endoglycosidase overexpression and
sequence-specific genome engineering is highlighted.
Address
Helmholtz Centre for Infection Research, Structure and Function of
Proteins, Inhoffenstr. 7, 38124 Braunschweig, Germany
Corresponding author: Bu¨ssow, Konrad
(konrad.buessow@helmholtz-hzi.de)
Current Opinion in Structural Biology 2015, 32:81–90
This review comes from a themed issue on New constructs and
expressions of proteins
Edited by Imre Berger and Roslyn M Bill
For a complete overview see the Issue and the Editorial
Available online 23rd March 2015
http://dx.doi.org/10.1016/j.sbi.2015.03.002
0959-440X/# 2014 The Author. Published by Elsevier Ltd. This is an
open access article under the CC BY license (http://creativecommons.
org/licenses/by/4.0/).
Introduction
Generating pure, soluble and homogeneous protein is a
major step in the overall process of protein structure
determination. The choice of the expression system
has a great influence on the quality and quantity of the
produced recombinant protein. The Human Embryonic
Kidney cell line HEK293 and the Chinese Hamster
Ovary cell line CHO are excellent host cells for robust
secretion of mammalian proteins with appropriate post-
translational modifications [1]. These cell lines are used
for production of secreted mammalian and viral proteins
and soluble ectodomains of transmembrane proteins,
but also for complete membrane proteins (Table 1).
Cytosolic proteins and complexes can be produced
with stable mammalian cell lines, but the yield is usually
low compared with other expression systems. The
long-awaited crystal structure of the cytosolic mTORCwww.sciencedirect.com complex was obtained upon overexpression of its sub-
units in a stable HEK293 cell line [2].
For recombinant protein overexpression, an expression
vector for the protein of interest is transferred into the
cell’s nucleus by transfection. In a transient transfection
experiment, the protein of interest is harvested a few days
later. Alternatively, a stable cell line is generated from
transfected cells that have integrated the vector into their
genome. Stable cell lines overexpress the target protein
uniformly and indefinitely. Protein production with a
stable cell line is therefore reproducible and can be scaled
up easily. Recent protein structure reports using HEK293
or CHO cell lines were surveyed for this review and it was
found that transient transfection and stable cell lines were
used with around the same frequency. New and improved
technologies for generating stable cell lines are expected
to increase their use in the future.
Establishing stable cell lines requires substantial time
and effort in comparison to transient transfection pro-
cesses. An expression vector with the gene of interest has
to be inserted into the host cell genome. Using standard
methods, the efficiency of genome integration is low.
Moreover, only very few cells will integrate the vector
into a highly transcribed region and will produce suffi-
cient amounts of recombinant protein. Even then, trans-
gene expression is often silenced upon long term cell
culture. Isolating and characterizing a large number of
clones is therefore required, which can take several
months of laboratory work. Fortunately, stable cell line
technology is improving rapidly on the levels of host cell
line, integration process and selection of high-producer
cells.
Crystal structures of proteins produced by stable cell lines
reported during the past two years are listed in
Table 1. The table provides an overview of the host cell
lines and experimental techniques currently used in
structural biology. The most common approach involves
transfection with vectors carrying a selectable marker for
random chromosomal integration, followed by isolation
and screening of single cell clones. This process was
reviewed in three recent publications [3,4,5] and proto-
cols for establishing stable cell lines for structural biology
with antibiotic selection markers have been published
[6,7]. The performance of the antibiotics hygromycin
B, neomycin, puromycin and Zeocin as selection markers
for stable cell line development was recently compared
[8].Current Opinion in Structural Biology 2015, 32:81–90
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Table 1
The Protein Data Bank (PDB) was searched for mammalian protein structures, excluding antibodies, that were released later than July
2012. Selected proteins that had been produced by stable cell lines are listed
Crystallized protein Host cell linea Vector Stable cell line
generationb
PDB entry
and Ref.
Cytosolic
proteins
mTOR:LST8 complex HEK293-F pcDNA 3.1 (+) Co-expression of mTORC
subunits using different
antibiotics
PDB: 4JSN [2]
Membrane
proteins
Rhodopsin HEK293 GnTI PDB: 4BEY [54]
GABAA receptor HEK293S GnTI PDB: 4COF [55]
5-HT3A receptor T-REx-293 pcDNA5/TO PDB: 4PIR [56]
Secreted
proteins
Prothrombin BHK pNUT Lipofection, MTX PDB: 4HZH [57]
Aminopeptidase N CHO Lec3.2.8.1 pBJ5-GS MSX PDB: 4F5C [22]
Integrin a4 CHO Lec3.2.8.1 pcDNA3.1/Hygro PDB: 4IRZ [58]
MHC class II HLA-DQ1:
antigen:TCR complex
CHO Lec3.2.8.1 pEE13.1 MSX PDB: 4GRL [21]
CD200 receptor CHO Lec3.2.8.1 pEE14 PDB: 4BFE [59]
DC-LAMP CHO Lec3.2.8.1 pFS-sigHis Electroporation, RMCE,
G418
PDB: 4AKM [39]
Neuroligin-1 CHO Lec3.2.8.1 pSGHV0 Electroporation, puromycin PDB: 3VKF [60]
HLA-DM CHO Lec3.2.8.1 PDB: 4FQX [61]
ICAM-5 CHO Lec3.2.8.1 MSX PDB: 4OI9 [20]
Tyrosine kinase receptor RET CHO Lec8 pcDNA3 Lipofection (Effectene), G418 PDB: 4UX8 [62]
Insulin receptor CHO Lec8 pEE14 Lipofection (Lipofectamine
2000), MSX
PDB: 3W11 [23]
Cholesteryl ester transfer
protein
CHO DG44 PDB: 4F2A [63]
Receptor tyrosine-kinase
erbB-4
CHO Lec1 pSGHV0 Lipofection (Fugene),
pcDNA3.1 co-transfection,
G418
PDB: 3U7U [64]
Folate receptor a CHO duk (kifu.) pSGHV0 Electroporation, MTX PDB: 4KM6 [14]
Acetylcholinesterase CHO-K1 pGS jetPEI, MSX PDB: 4BDT [24]
LIMP-2 HEK293S GnTI pNeoSec FC31 integrase (stable cell
pool)
PDB: 4Q4B [42]
Glutamate receptor 4 HEK293 GnTI pHLsec PDB: 4GPA [65]
Tumor antigen 5T4/WAIF1 HEK293 GnTI pURD FC31 integrase, puromycin PDB: 4CNC [48]
Transcobalamin-1 HEK293 GnTI Lipofection (lipofectamine) PDB: 4KKI [66]
Integrin aXb2 heterodimer HEK293S GnTI
 ET1 (pIRES2-EGFP),
pEF1-puro
Ca-phosphate, FACS,
puromycin,
G418
PDB: 4NEH [29]
von Willebrand factor HEK293S GnTI ET8 PEI, G418 PDB: 4NT5 [67]
Aminopeptidase N HEK293S GnTI PDB: 4FYQ [68]
NPP1 pyrophosphatase HEK293S GnTI PDB: 4B56 [69]
Angiopoietin-2 HEK293 pcDNA3.1 hygro Lipofection PDB: 4JZC [70]
Netrin-1:neogenin complex HEK293 pcDNA3.1+ PDB: 4PLN [71]
RNaseT2 HEK293 (kifu.) pcDNA3.1/myc-His Lipofection (Effectene) PDB: 3T0O [15]
TGF-b-receptor-3 HEK293 EBNA Lipofection (Lipofectamin
2000), puromycin
PDB: 4AJV [72]
Folate receptor a HEK293 pcDNA6 blasticidin PDB: 4LRH [73]
IgG receptor FcRn
subunit p51
HEK293-6E pLVX Lentivirus PDB: 4K71 [46]
Nectin1, 2, 3, Necl-5. HEK293-F pCEP4 Lipofection (Lipofectamin
2000), hygromycin B
PDB: 4FMF [74]
Monocyte differentiation
antigen CD14
HEK293-F pDisplay G418 PDB: 4GLP [75]
Acetylcholinesterase HEK293-H pJT1 Fast Dest Lipofection (Lipofectamin
2000), FC31, hygromycin B
PDB: 4EY4 [49]
Platelet glycoprotein Ib HEK293T ET-6 PDB: 4C2A [76]
Galactocerebrosidase HEK293T pSecTag2B PDB: 4CCC [77]
O-fucosyltransferase 2 HEK293T (kifu.) pSecTagB jetPEI, zeocin PDB: 4AP5 [13]
a kifu., the GnTI inhibitor kifunensine was used during protein production.
b Cells were transfected by lipofection, electroporation or with polyethylenimine (PEI, jetPEI). Recombinant cells were selected with antibiotics
(blasticidin, G418, hygromycin B, puromycin, Zeocin), with the glutamine synthase inhibitor methionine sulfoximine (MSX) or with the DHFR inhibitor
methotrexate (MTX). FACS, GFP-positive cells were isolated by cell sorting.
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line generation
Glycosylation-deficient cell lines
Most secreted mammalian proteins are glycosylated,
which can interfere with crystallization [9]. Glycosyla-
tion sites that are not required for folding or secretion are
therefore removed by mutagenesis [9]. The processing
of N-linked glycans from the high-mannose type to the
larger, complex type requires the enzyme N-acetylglu-
cosaminyl-transferase I (GnTI, MGAT1) (Figure 1). The
GnTI-deficient host cell lines HEK293S GnTI and
CHO Lec3.2.8.1 produce glycoproteins with high-man-
nose type glycans. These glycans can be readily trimmed
further to a single GlcNAc sugar unit by endoglycosidase
treatment [10,11]. The HEK293S GnTI cell line [10]
(ATCC CRL-3022) is currently the most popular cell line
in structural biology (Table 1). It is used for transient and
stable expression. High-mannose type glycosylation is
also obtained by cultivation with the GnTI inhibitor
kifunensine [12]. Kifunensine was applied for crystal
structure determination of the glycoproteins O-fucosyl-
transferase [13], folate receptor a [14] and RNaseT2 [15]
(Table 1).
Intracellular endoglycosidase overexpression
Recently the ‘GlycoDelete’ HEK293 cell line was devel-
oped that carries a heterologous endoglycosidase in its
Golgi apparatus [16]. This resulted in robust secretionFigure 1
(GlcNAc)2Man5(GnTI– cells)
Complex type
(wildtype cells)
NeuAc-Gal-GlcNAc
(GlycoDelete Endo T+ cells)
N-Acetylneuramic acid (NeuAc)
Galactose (Gal)
N-Acetylglucosamine (GlcNAc)
Mannose (Man)
Asn Asn Asn
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N-linked sugar classes produced by mammalian cell lines. Complex-
type glycans are synthesized as a heterogeneous mixture of bi-
antennary, tri-antennary and tetraantennary forms. Lack of N-
acetylglucosaminyl-transferase I (GnTI) prevents the formation of
complex sugars and results in high-mannose type protein
glycosylation. High-mannose sugars consist of a variable number of
mannose residues attached to a chitobiose (GlcNAc2) core.
Overexpression of endoglycosidase T (Endo T) in the Golgi apparatus
of the GnTI ‘GlycoDelete’ HEK293 cell line leads to intracellular
cleavage of N-linked sugars after the first GlcNAc residue. The
cleavage product is partly modified with galactose and N-
acetylneuramic acid residues.
www.sciencedirect.com of deglycosylated glycoproteins (Figure 1). The Glyco-
Delete study demonstrates that protein deglycosylation is
possible in the Golgi apparatus, where glycoproteins
traveling the secretory pathway have already passed
the quality control in the endoplasmic reticulum. Cells
that secrete glycoproteins with minimal glycosylation
would enable crystallization without further in vitro
deglycosylation.
Sequence-specific genome engineering
The cell lines CHO Lec3.2.8.1 and HEK293S GnTI
were created by chemical mutagenesis, followed by
selection for glycosylation deficiency. Chemical muta-
genesis lacks specificity, leading to random mutations
throughout the genome. Sequence-specific genome en-
gineering represents an elegant alternative that greatly
reduces unwanted mutations. Meganucleases with long
recognition sequences cleave genomic DNA at rare sites
and can be used to introduce gene-inactivating mutations
more specifically [17]. Nucleases linked to programma-
ble, sequence-specific DNA-binding modules, such as
zinc finger nucleases (ZFN), TALE nucleases and the
CRISPR/Cas9 nucleases allow for modification of arbi-
trary genetic loci with excellent specificity [18]. Both
alleles of a gene can be inactivated with high frequency
with these nucleases. Especially with CRISPR/Cas9,
mammalian genome engineering has become simple,
reliable and cheap [19].
Glutamine synthetase knockout cells
The glutamine synthetase (GS) gene is used widely as a
selection marker for stable CHO cells. Cells overexpres-
sing GS can be selected by inhibiting the endogenous
glutamine synthetase with the inhibitor methionine sul-
foximine (MSX). The GS marker and MSX-selection of
stable CHO cell lines were used to produce protein for
structure determination of the ICAM-5 ectodomain [20],
a TCR:MHC:antigen heterotetramer [21], aminopepti-
dase N [22], the insulin receptor ectodomain [23] and
acetylcholinesterase [24]. A novel CHO host cell was
created by knocking out the GS gene and the GnTI gene
with specific zinc finger nucleases [25]. With GS-defi-
cient CHO host cells, MSX selection of cells stably
transfected with a GS vector is much more efficient than
with normal cells. The selection of low-producing cell
clones was largely prevented by using a GS-deficient host
cell line [26]. Moreover, among MSX-selected, stably
transfected cell clones, a six-fold higher proportion of
top producing clones (>2 g/L) was found when a GS-
deficient host cell line was used, in comparison to the
original host cell line.
New cell lines developed by sequence-specific genome
engineering such as GnTI and GS double knockouts
are potentially useful for structural biology. Genome
engineering could also be used for removing genes ofCurrent Opinion in Structural Biology 2015, 32:81–90
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target protein.
Methods of stable cell line generation
GFP and cell sorting
Transgene insertion into a host cell chromosome upon
transfection is a rare event and, to make things worse,
most of the integrated transgenes will be inactivated by
epigenetic mechanisms. Cells that received an active
genome-integrated transgene therefore have to be select-
ed by a marker. Antibiotic resistance is commonly used,
but can be an unreliable reporter for high level, uniform
transgene expression [27]. Green fluorescent protein
(GFP) is a useful alternative [28]. Cells that stably inte-
grate a GFP expression vector are directly identified by
intracellular fluorescence and can be isolated by prepara-
tive FACS cell sorting. Cell sorting can isolate a small
number of high-producer clones from millions of cells. By
repeating the process at different time points, cells that
express GFP stably over time can be isolated. By this
method, clonal cell lines with constantly high GFP ex-
pression over several months can be obtained without
applying selective pressure [27].
GFP expression can be coupled to expression of the gene
of interest by constructing internal ribosome entry site
(IRES)-based bicistronic vectors comprising the gene of
interest and a GFP gene. IRES-based GFP co-expression
in combination with cell sorting and antibiotic selection
was used to generate a stable HEK293S GnTI cell line
for production of a soluble integrin aXb2 heterodimer for
structure determination [29]. In an alternative approach,
the GFP gene can be excised by site-specific recombina-
tion upon clone isolation, thereby bringing a gene ofFigure 2
GOI
GO
GOI
Flp
FRTP
FRTGFPFRTP
FRT
GFP
FRTP
(a)
(b)
(c)
Replacing a GFP marker with a gene of interest by Flp-mediated excision for 
cell line is established by cell sorting. (b) Then, the GFP gene is replaced by t
recombinase. Flp mediates recombination of the FRT-sites flanking the GFP-g
becomes activated by the transgene’s promoter. P: promoter, GOI: gene of in
Figure adapted from Wilke et al. [30].
Current Opinion in Structural Biology 2015, 32:81–90 interest, located downstream, under the control of the
promoter driving transgene expression (Figure 2) [27,30].
Cell sorting may require optimization to maintain cell
viability. In our own experience, the viability of CHO
Lec3.2.8.1 cells grown in suspension can be low upon cell
sorting. Shear stress was reported to cause low cell viabil-
ity upon sorting of insect cell lines. Addition of Pluronic
acid F-68 improved the survival of sorted insect cells [31]
and may also have a positive effect on mammalian cells.
Secreted GFP fusion proteins
A secreted GFP marker was used for studying the struc-
ture of a sialyltransferase [32]. The sialyltransferase was
fused to a codon-optimized, folding-enhanced GFP ver-
sion called ‘superfolder’ [33]. The fusion protein was
secreted by a stable HEK293S GnTI cell line with high
yield (75 mg/L). The GFP tag allowed for direct protein
quantification by fluorescence spectroscopy during cell
line development and protein purification. It was re-
moved by proteolysis from the sialyltransferase before
crystallization.
Recombinase-mediated cassette exchange
The productivity of a stable cell line depends on the
genetic locus of transgene integration. Instead of random
integration, it would be desirable to target the transgene to
a specific locus that allows for strong and stable transgene
transcription. This can be achieved by recombinase-
mediated cassette exchange (RMCE) using site-specific
recombinases [34,35]. RMCE requires a ‘master’ cell line
carrying a single copy of a reporter gene at a suitable
genetic locus. By RMCE, the reporter gene is exchanged
against the gene of interest (GOI). For RMCE with theI Cell line with stablygenome-integrated GFP
gene.
Recombination by
transient Flp expression.
GFP is excised and the
gene of interest is
activated by the promoter.
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generating stable producer cell lines [27]. (a) First, a stable GFP-positive
he gene of interest. This is achieved by transient overexpression of Flp
ene, which leads to the gene’s excision. (c) The gene of interest now
terest, FRT: Flp recognition target site.
www.sciencedirect.com
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by two distinct Flp recognition target (FRT) sites that have
been engineered so that they cannot recombine with each
other (Figures 3 and 4). RMCE is initiated by introducing
the Flp recombinase and a vector with the gene of interest
(GOI), flanked by FRT sites, into the master cell line.
Recombination of FRT sites leads to exchange of the
reporter gene and the GOI, placing the GOI at a highly
active, stable genetic locus (Figure 4). The same master
cell line can be used for generating producer cell lines for
many different target proteins [34,35].
The stable CHO Lec3.2.8.1 cell line SWI3a-26 is a master
cell line for RMCE that was generated by random inte-
gration of a FRT-flanked GFP reporter gene [36]. It
contains a single copy of the GFP reporter transgene at
a genetic locus that is protected from silencing. The
integrated GFP cassette contains a ‘selection trap’ that
allows for selection of recombinant cells upon RMCE
[37]. The selection trap is an inactive selection marker,
lacking a promoter and a start codon (Figure 4). It is
complemented upon RMCE and allows for antibiotic
selection of recombinant cells. Using SWI3a-26, produc-
tion cell lines were established by RMCE for different
mammalian glycoproteins [36,38], including the ectodo-
main of the lysosomal membrane protein DC-LAMP. In
consequence, the DC-LAMP domain structure was
solved by X-ray crystallography [39].
In our experience, RMCE takes about 7 weeks from the
day of transfection to cryopreservation of clonal produc-
tion cell lines [36]. In comparison to random integration,
the process is faster and the effort of screening of large
numbers of clones is avoided. The multi-host expression
vector pFlpBtM allows for protein production in E. coli,
transiently transfected mammalian cells and Baculovirus-
infected insect cells and for construction of stable cell
lines by RMCE with a single vector [38].
RMCE-derived production cell lines contain only a single
copy of the transgene. Nevertheless, high-yield antibody
production of up to 2 g/L shake flask culture was achieved
with an RMCE system that uses Cre-lox recombination
[40]. With this system, about 5 weeks were required
from transfection to completion of stable pool production
cultures.
Two independent genetic loci can be targeted with two
different transgenes by RMCE with a single transfection.
This has been achieved by designing new synthetic FRT
site variants [41].
Transfection efficiency and stable pools
Transfection of HEK293 and CHO cells leads to integra-
tion of transgene DNA at random chromosomal loci, but
the frequency of these integration events is very low
with commonly used vectors. Highly efficient systemswww.sciencedirect.com for chromosomal integration of transgenes accelerate cell
line generation and allow for protein production with
stable pools, thereby eliminating time-consuming cloning
steps. For protein production with a stable pool, the bulk
of stably transfected cells are selected and used directly
for protein production. The structure of lysosomal inte-
gral membrane protein (LIMP2) was solved using a stable
pool obtained by transfection with the FC31 integrase
system (described below) and antibiotic selection [42].
Efficient chromosomal integration is also achieved with
Lentivirus particles and transposons (Figure 3).
Lentivirus
Lentiviral transduction of mammalian cells is very effi-
cient and highly productive cells are generated at a high
frequency. The usefulness of the Lentivirus system was
demonstrated by establishing stable cell lines and stable
pools for production of antibodies and blood coagulation
factor VIII [43,44,45]. The Lentivirus efficiently trans-
ports the transgene cDNA into the nucleus, where it is
integrated into the host cell genome by the viral integrase
(Figure 3). A stable cell line for production of an IgG
receptor subunit, which resulted in crystal structure
determination, was established with a recombinant
Lentivirus [46]. Stable cell line generation by Lentivirus
transduction and by non-viral plasmid transfection was
compared [45]. Gene delivery into nearly 100% of CHO
cells grown in serum-free suspension culture was
obtained by Lentivirus. GFP overexpression was up to
five times higher in comparison to plasmid transfection.
Potential drawbacks of the Lentivirus system are safety
concerns, the error-prone replication of the viral RNA
genome by reverse transcription and the extra step of
virus particle preparation.
Phage FC31 integrase
The integration system of the Streptomyces phage FC31
represents a non-viral alternative for active transgene
integration. The FC31 integrase performs recombination
between the attP site of the phage genome and the attB
site in the host bacterial chromosome. In mammalian
cells, it mediates integration of plasmids bearing an attB
site into chromosomal sequences that have sequence
similarity with attP, termed pseudo attP sites [47]. Stable
mammalian cell lines are generated by co-transfection
with a FC31 integrase expression vector and an expres-
sion vector for the gene of interest that has an attB site
(Figure 3). This system was used for protein production
and structure determination of LIMP-2 [42], tumor anti-
gen 5T4 [48] and acetylcholinesterase [49].
Transposons
High rates of chromosomal integration have also been
achieved with transposon vectors. The terminal inverted
repeats of the ‘piggyBac’ transposon are recognized by
the transposon’s integrase, which leads to integration of
the flanked sequence into a chromosomal TTAA siteCurrent Opinion in Structural Biology 2015, 32:81–90
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Techniques of transgene genome integration for generating stable cell lines. Random integration: The linearized expression vector with the gene of
interest (yellow) is integrated by non-homologous end joining into the host cell genome at the position of a random chromosome break. RMCE
(recombinase-mediated cassette exchange): A master cell line, engineered to carry FRT sites at a suitable locus of its genome, is co-transfected
with a vector with an FRT-flanked gene of interest (GOI) and a second vector for overexpression of Flp recombinase. The Flp recombinase
catalyses site-specific genome integration of the GOI (see also Figure 4). Lentivirus: The host cell line is transduced by a Lentivirus that carries the
GOI in its genome. The viral RNA genome is reverse-transcribed into cDNA, which is integrated into the host cell genome by the viral integrase at
random locations. FC31 integrase: The host cell line is co-transfected with an expression vector for phage FC31 integrase and an expression
vector for the GOI which contains an attB recombination site. The FC31 integrase is expressed and catalyses recombination of the attB site with
genomic sequences that resemble the attP recombination site (pseudo attP sites). Transposase: The host cell line is co-transfected with an
expression vector for the transposase of the piggyBac transposon and a vector containing the GOI, flanked by the transposon’s inverted terminal
repeats. The integrase recognizes the repeats and integrates the flanked sequence into a chromosomal TTAA site.
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Figure 4
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Recombinase-mediated cassette exchange (RMCE) with the CHO Lec3.2.8.1 cell line SWI3a-26 [36]. (1) The SWI3a-26 master cell line was
generated from CHO Lec3.2.8.1 cells by random integration of a vector with a GFP reporter gene, flanked by a wild-type FRT site and a synthetic
variant (FRT3). The cell line was isolated by cell sorting and contains a single copy of the GFP vector integrated at a genomic locus that allows for
high-level gene expression. The GFP vector contains a selection trap consisting of an inactive neomycin resistance gene, Dneo, that lacks a
promoter and a start codon. (2) Cassette exchange is initiated by co-transfecting the master cell line with vectors for the Flp recombinase and the
gene of interest (GOI), flanked by compatible FRT sites. The transiently expressed Flp recombinase exchanges the FRT-flanked cassettes. The
selection trap is triggered by activating the Dneo gene with a promoter and a start codon from the GOI vector, thereby enabling selection of
recombinant clones.
Figure adapted from Wilke et al. [36].(Figure 3). In stable CHO cell development, the piggy-
Bac system strongly increased the frequency of stable
integration and lead to up to fourfold higher protein yield
from pools of transfected cells [50]. Similarly positive
results were obtained with the ‘Sleeping Beauty’ trans-
poson system and HEK293 cells [51]. A stable cell line
overexpressing the four subunits of a g-secretase complex
was established in one step with the piggyBac system
[52]. A newly designed vector set for doxycycline-in-
ducible overexpression utilizes multiple-copy integration
by the piggyBac integrase and was used with HEK293S
GnTI cells for high-level secretion of 14 proteins with
stable pools [53].
Conclusions
Protein production with stable cell lines for structural
biology relies strongly on glycosylation-deficient host cells.
A novel HEK293 cell line, called ‘GlycoDelete’, was
equipped with an intracellular endoglycosidase for secre-
tion of deglycosylated glycoproteins. Host cells can be
improved by sequence-specific genome engineering, allow-
ing for efficient and highly specific knock out of multiple
genes. A CHO cell was reported that lacks both GnTI and
glutamine synthetase (GS) activity, which allows for highly
efficient selection of stable cell lines with GS markers.www.sciencedirect.com A survey of recent reports of protein crystal structures
indicated that transient transfection of mammalian cells
and stable mammalian cell lines were used with around
the same frequency. In comparison to transient transfec-
tion protocols, the generation of stable cell lines has
several bottlenecks. The frequency of stable genome
integration upon transfection with plasmid vectors is
low and, moreover, most integrated transgenes will be
silenced. Top producers are usually rare in the pool of
stably transfected cells and their identification requires
isolating and characterizing a large number of clones.
Techniques for improved genome integration of trans-
genes and for improved selection of high-producing
stable cell lines have been developed. Using fluorescent
proteins as selection markers allows for isolating high-
producing stable cells among millions of transfected cells
by cell sorting. Novel glutamine synthetase knock out
cells generated by sequence-specific genome engineering
allow for a more efficient selection of high-producer cells
with the glutamine synthetase selection marker. The
problem of transgene silencing has been addressed by
the recombinase-mediated cassette exchange (RMCE)
technique. Here, site-specific recombination is used for
targeting the gene of interest to specific genetic loci thatCurrent Opinion in Structural Biology 2015, 32:81–90
88 New constructs and expressions of proteinsare protected from silencing and that allow for high-level
gene expression.
Plasmid DNA introduced into the nucleus of host cells is
integrated into the genome by host cell factors at random
sites with a low frequency. Much more efficient genome
integration is achieved when additional, heterologous
integration factors are introduced. This is accomplished
with Lentiviruses, piggyBag and Sleeping Beauty trans-
posons and the phage FC31 integrase. Transfection of
host cells with these highly efficient systems results in a
pool of cells with a high proportion of stable high-produ-
cers. Such a stable pool can be used directly for protein
production, thereby avoiding time-consuming clone
isolation and characterization steps.
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